Vaccine Confidence Quality and Innovation Collective (QuIC)
AMGA’s new Vaccine Confidence Quality and Innovation Collective (QuIC) is a three-phase initiative, designed to help healthcare organizations develop and implement vaccine confidence techniques and tools with their providers, staff, and patients.
The Vaccine Confidence QuIC utilizes interactive workshops with quality improvement tools and qualitative methodology to engage AMGA member organizations in thoughtful discussions to collect insights and share best practices on creating and implementing successful vaccine confidence techniques and tools.
This program will build on the Focus Group that AMGA members participated in on February 20, 2026.
Opportunity
Up to 10 medical groups and health systems will be asked to participate in the Vaccine Confidence QuIC and will focus on the following key areas:
- Assess current and past success and challenges with language, techniques and tools used to improve vaccine confidence
- Strategies to target underserved populations in vaccination confidence efforts
- Utilize surveys to assess HCP knowledge, attitudes, and beliefs about vaccines
- Use of motivational interviewing or other behavioral techniques to improve vaccine confidence
The Vaccine Confidence QuIC will include a virtual discussion forum, a two-day in-person meeting, and a two-day virtual meeting.
Listen: Virtual Discussion Forum
October 15, 2026, 1-2:30 PM ET
Listen and engage in a 90-minute moderated discussion session that will focus on improving vaccine confidence.
Share: Two-Day In-Person Working Session
February 16-18, 2027
Share in educational sessions and interactive activities on developing and implementing vaccine confidence techniques and tools within organizations.
Create: Two-Day Virtual Meeting
October 19-20, 2027
Create and engage in:
- A meeting on your organization’s next steps for a newly approved vaccine.
- hands-on and interactive learning with direct goals and objectives
- a meeting that will incorporate group work, roundtables, panels, and lecture presentations, and offers participants opportunities to collaborate with one another in a structured learning environment.
Benefits of Participation
✔ Participating organizations will receive a $7,500 honorarium.
✔ Exclusive opportunity to engage in interactive discussion with AMGA members and vaccination experts.
✔ Incorporate quality improvement techniques, best practices, operational tips, techniques, tools and resources from other leading medical groups and health systems.
✔ Improve value through better patient care and outcomes (quality and value).
✔ A best practices summary highlighting your insights from each meeting will be published, as well as a best practices guide of successfully tested techniques and tools from HCOs, including insights and implementation strategies.
How to join?
Enrollment closes on Wednesday, July 1, 2026. Spots are limited and granted on a first-come, first-served basis. Email Saleaha Pirzada to secure your place!
Click here to learn more about this Vaccine Confidence QuIC and its timeline.
Vaccine Confidence QuIC Advisory Committee
-
Erica Chilson, PharmD
Senior Director of US Medical Affairs, Pfizer Inc. -
Stephen Parodi, MD
EVP, Associate Executive Director, TPMG and EVP, The Permanente Federation, The Permanente Medical Group, Inc. -
Carrie Regnier, DNP, MPH, RN, NEA-BC
Director, Patient Care, Norton Medical Group -
Carole Stipelman, MD, MPH, FAAP
Professor of Pediatrics, University of Utah Health
If your organization is interested in learning more about this QuIC program, please contact Erin Leaver-Schmidt
The Vaccine Confidence QuIC is sponsored by Pfizer:
